• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Nutrien Reports First Quarter 2026 Results

    5/6/26 5:00:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials
    Get the next $NTR alert in real time by email

    Strong customer demand and solid operational performance in the first quarter

    Strategic priorities and capital allocation approach remain unchanged

    Full-year guidance ranges reaffirmed

    All amounts are in US dollars, except as otherwise noted

    Nutrien Ltd. (TSX and NYSE:NTR) announced today its first quarter 2026 results, with net earnings of $139 million ($0.27 diluted net earnings per share). First quarter 2026 adjusted EBITDA1 was $1.11 billion and adjusted net earnings per share1 was $0.51.

    "Nutrien delivered record potash sales volumes and stronger Nitrogen and Retail performance in the first quarter. We increased production from our low-cost North American assets and positioned our supply chain to reliably supply our customers amid tightening global fertilizer supply and demand fundamentals," commented Ken Seitz, Nutrien's President and CEO. "We continue to take purposeful steps to simplify the business, strengthen and grow our core asset base and improve capital efficiency, resulting in a more resilient portfolio and delivering structural free cash flow growth."

    Highlights2:

    • Retail adjusted EBITDA increased to $108 million in the first quarter of 2026 due to higher crop nutrient sales volumes and stronger proprietary products gross margins in the US and Australia. In the first quarter, we completed a tuck-in acquisition of a high-quality retail business located in the US corn belt.
    • Potash adjusted EBITDA increased to $578 million in the first quarter of 2026 due to higher global benchmarks and record sales volumes. We increased potash production and continued to progress mine automation, maintaining our controllable cash cost of product manufactured1 below $60 per tonne.
    • Nitrogen adjusted EBITDA increased to $482 million in the first quarter of 2026 primarily due to higher global benchmarks. Our low-cost North American nitrogen plants delivered an ammonia operating rate3 of 92 percent in the first quarter of 2026, consistent with our planned production and reflective of a continued focus on reliability initiatives.
    • Returned $409 million to shareholders in the first quarter of 2026 through dividends and share repurchases.
    • Progressing as planned with the review of strategic alternatives for our Phosphate business, Trinidad Nitrogen facility and Brazilian Retail business with a focus on enhancing earnings quality and free cash flow.

     

    1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section. All references to per share amounts pertain to diluted net earnings per share, unless otherwise noted.
    2 Our discussion of highlights set out on this page is a comparison of the results for the three months ended March 31, 2026 to the results for the three months ended March 31, 2025, unless otherwise noted.
    3 Excludes Trinidad and Joffre.
     

    Management's Discussion and Analysis

    The following management's discussion and analysis ("MD&A") is the responsibility of management and is dated as of May 6, 2026. The Board of Directors ("Board") of Nutrien carries out its responsibility for review of this disclosure principally through its Audit Committee, composed entirely of independent directors. The Audit Committee reviews and, prior to its publication, approves this disclosure pursuant to the authority delegated to it by the Board. The term "Nutrien" refers to Nutrien Ltd. and the terms "we", "us", "our", "Nutrien" and "the Company" refer to Nutrien and, as applicable, Nutrien and its direct and indirect subsidiaries on a consolidated basis. Additional information relating to Nutrien (which, except as otherwise noted, is not incorporated by reference herein), including our annual report dated February 19, 2026 ("2025 Annual Report"), which includes our annual audited consolidated financial statements ("annual financial statements") and MD&A, and our annual information form dated February 19, 2026, each for the year ended December 31, 2025, can be found on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. No update is provided to the disclosure in our 2025 annual MD&A except for material information since the date of our annual MD&A. The Company is a foreign private issuer under the rules and regulations of the US Securities and Exchange Commission (the "SEC").

    This MD&A is based on, and should be read in conjunction with, the Company's unaudited interim condensed consolidated financial statements as at and for the three months ended March 31, 2026 ("interim financial statements") based on International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board and prepared in accordance with International Accounting Standard ("IAS") 34 "Interim Financial Reporting", unless otherwise noted. This MD&A contains certain non-GAAP financial measures and ratios and forward-looking statements, which are described in the "Non-GAAP Financial Measures" and the "Forward-Looking Statements" sections, respectively.





    Market Outlook and Guidance

    • The conflict in the Middle East and related geopolitical uncertainty has disrupted global fertilizer and energy markets, with the most direct impact on nitrogen and phosphate supply from that region, as well as associated feedstock cost and availability. The outlook below reflects current market conditions and ongoing market dynamics.

    Agriculture and Retail Markets

    • Higher global grain and oilseed production in 2025 increased stocks-to-use ratios towards historical average levels and led to significant nutrient removal from the soil. Strong demand for food, feed and biofuel is expected to drive continued need for higher global crop production and related crop inputs. Global grain and oilseed prices have strengthened in 2026 due to robust demand and the emergence of regional weather issues that could impact prospective production.
    • We have maintained our US crop acreage projections with corn plantings of 94 to 96 million acres and soybean plantings of 84 to 86 million acres in 2026. We have seen healthy crop input demand over the first four months of 2026 in line with our prior expectations, supported by above average planting progress and the need to replenish soil nutrients following last year's record crop.
    • In Australia, favorable weather conditions across key cropping regions and strong livestock prices are supporting sales of retail products and services. In Brazil, safrinha corn planting supported crop input demand in the first quarter and growers prioritized potash purchases.

    Crop Nutrient Markets

    • Global potash demand remains strong and we have maintained our previous forecast range for global potash shipments of 74 to 77 million tonnes in 2026. We anticipate relatively tight potash fundamentals throughout 2026 with demand trends expected to test existing global operating and supply chain capabilities.
    • Global nitrogen market fundamentals have tightened due to trade flow disruptions and elevated natural gas costs and LNG availability have impacted nitrogen production and costs for producers in Asia, Europe and other key regions. The outlook for the remainder of 2026 is expected to be impacted by uneven restoration of trade flows and restart of nitrogen assets, as well as uncertainty regarding Chinese urea exports and Indian urea imports.
    • Global phosphate supply and demand has been impacted by trade flow disruptions, lower global operating rates due to elevated feedstock costs that have pressured margins, and continued uncertainty regarding Chinese exports.

    Financial and Operational Guidance

    • We have maintained all 2026 full year financial and operational guidance ranges.
    • Retail adjusted EBITDA guidance of $1.75 to $1.95 billion represents structural growth in our downstream business consistent with historical rates.
    • Potash sales volume guidance of 14.1 to 14.8 million tonnes is consistent with our global shipment expectation.
    • Nitrogen sales volume guidance of 9.2 to 9.7 million tonnes is supported by planned reliability improvements and debottlenecks.
    • Phosphate sales volume guidance of 2.4 to 2.6 million tonnes reflect the benefits of reliability improvement initiatives completed in 2025.
    • Total capital expenditures guidance of $2.0 to $2.1 billion is consistent with 2025 as we continue to optimize capital to sustain safe and reliable operations and to progress a set of targeted growth investments. The total includes approximately $400 million in investing capital expenditures focused on proprietary products, network optimization and digital capabilities in Retail, low-cost brownfield expansions and product optimization projects in Nitrogen, and mine automation in Potash.

    All guidance numbers, including those noted above, are outlined in the table below. Refer to page 33 of our 2025 Annual Report for anticipated fertilizer pricing and natural gas price sensitivities relating to adjusted EBITDA (consolidated) and adjusted net earnings per share.

     

    2026 Guidance Ranges1 as of

     

    May 6, 2026

     

    February 18, 2026

    ($ billions, except as otherwise noted)

    Low

     

    High

     

    Low

     

    High

    Retail adjusted EBITDA

    1.75

     

    1.95

     

    1.75

     

    1.95

    Potash sales volumes (million tonnes)2

    14.1

     

    14.8

     

    14.1

     

    14.8

    Nitrogen sales volumes (million tonnes)2

    9.2

     

    9.7

     

    9.2

     

    9.7

    Phosphate sales volumes (million tonnes)2

    2.4

     

    2.6

     

    2.4

     

    2.6

    Depreciation and amortization

    2.4

     

    2.5

     

    2.4

     

    2.5

    Finance costs

    0.65

     

    0.75

     

    0.65

     

    0.75

    Effective tax rate on adjusted net earnings (%)3

    24.0

     

    26.0

     

    24.0

     

    26.0

    Capital expenditures4

    2.0

     

    2.1

     

    2.0

     

    2.1

    1 See the "Forward-Looking Statements" section.

    2 Manufactured product only.

    3 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

    4 Comprised of sustaining capital expenditures, investing capital expenditures and mine development and pre-stripping capital expenditures, which are supplementary financial measures. See the "Other Financial Measures" section.

     





    Consolidated Results

     

    Three Months Ended

    March 31

    ($ millions, except as otherwise noted)

    2026

     

    2025

     

    % Change

    Sales

    6,046

     

    5,100

     

    19

    Gross margin

    1,646

     

    1,320

     

    25

    Expenses

    1,286

     

    1,094

     

    18

    Net earnings

    139

     

    19

     

    n/m

    Adjusted EBITDA1

    1,105

     

    852

     

    30

    Diluted net earnings per share (dollars)2

    0.27

     

    0.02

     

    n/m

    Adjusted net earnings per share (dollars)1, 2

    0.51

     

    0.11

     

    n/m

    1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

    2 All references to per share amounts pertain to diluted net earnings per share, unless otherwise noted.

    Net earnings and adjusted EBITDA increased in the first quarter of 2026 primarily due to higher fertilizer global benchmarks, increased Retail earnings and record Potash sales volumes compared to the first quarter of 2025.





    Segment Results

    Our discussion of segment results set out on the following pages is a comparison of the results for the three months ended March 31, 2026 to the results for the three months ended March 31, 2025, unless otherwise noted.

    Retail

     

    Three Months Ended

    March 31

    ($ millions, except as otherwise noted)

    2026

     

    2025

     

    % Change

    Sales

    3,640

     

    3,090

     

    18

    Cost of goods sold

    2,840

     

    2,404

     

    18

    Gross margin

    800

     

    686

     

    17

    Adjusted EBITDA1

    108

     

    46

     

    135

    1 See Note 2 to the interim financial statements.

    • Retail adjusted EBITDA increased in the first quarter of 2026 due to higher crop nutrient sales volumes and stronger proprietary products gross margins in the US and Australia. Expenses increased due to selling expenses related to higher sales volumes.

     

    Three Months Ended

    March 31

     

    Sales

     

    Gross Margin

    ($ millions)

    2026

     

    2025

     

    2026

     

    2025

    Crop nutrients

    1,483

     

    1,194

     

    250

     

    219

    Crop protection products

    1,137

     

    972

     

    226

     

    191

    Seed

    562

     

    532

     

    84

     

    70

    Services and other

    175

     

    146

     

    144

     

    118

    Merchandise

    223

     

    189

     

    36

     

    31

    Nutrien Financial

    80

     

    70

     

    80

     

    70

    Nutrien Financial elimination1

    (20)

     

    (13)

     

    (20)

     

    (13)

    Total

    3,640

     

    3,090

     

    800

     

    686

    1 Represents elimination of the interest and service fees charged by Nutrien Financial to Retail branches.

    • Crop nutrients sales and gross margin increased in the first quarter of 2026 due to higher sales volumes from our core geographies, including an earlier start to field activity in the US relative to the same period in 2025.
    • Crop protection products sales and gross margin increased in the first quarter of 2026 due to higher sales of proprietary products, supported by earlier field activity in the US relative to the same period in 2025.
    • Seed sales and gross margin increased in the first quarter of 2026 due to higher sales volumes, including higher-margin canola seed.
    • Services and other sales and gross margin increased in the first quarter of 2026 due to a strong livestock market in Australia.

    Supplemental Data

    Three Months Ended

    March 31

     

    Gross Margin

     

    % of Product Line1

    ($ millions, except as otherwise noted)

    2026

     

    2025

     

    2026

     

    2025

    Proprietary products

     

     

     

     

     

     

     

    Crop nutrients

    80

     

    69

     

    32

     

    31

    Crop protection products

    88

     

    53

     

    38

     

    28

    Seed

    21

     

    28

     

    25

     

    40

    Merchandise

    2

     

    3

     

    6

     

    9

    Total

    191

     

    153

     

    24

     

    22

    1 Represents percentage of proprietary product margins over total product line gross margin.

    Three Months Ended

    March 31

     

    Sales Volumes

    (tonnes
    – thousands)

     

    Gross Margin / Tonne

    (dollars)

     

    2026

     

    2025

     

    2026

     

    2025

    Crop nutrients

     

     

     

     

     

     

     

    North America

    1,600

     

    1,464

     

    131

     

    130

    International

    848

     

    826

     

    48

     

    34

    Total

    2,448

     

    2,290

     

    102

     

    95

     

    (percentages)

    March 31, 2026

     

    December 31, 2025

    Financial performance measures1, 2

     

     

     

    Cash operating coverage ratio

    62

     

    62

    Average working capital to sales

    23

     

    22

    1 Rolling four quarters.

    2 These are non-GAAP financial measures. See the "Non-GAAP Financial Measures" section.

    Potash

     

    Three Months Ended

    March 31

    ($ millions, except as otherwise noted)

    2026

     

    2025

    % Change

    Net sales

    926

     

    744

     

    24

    Cost of goods sold

    422

     

    380

     

    11

    Gross margin

    504

     

    364

     

    38

    Adjusted EBITDA1

    578

     

    446

     

    30

    1 See Note 2 to the interim financial statements.

    • Potash adjusted EBITDA increased in the first quarter of 2026 due to higher global benchmarks and record sales volumes. We increased potash production and continued to progress mine automation, maintaining our controllable cash cost of product manufactured1 below $60 per tonne.

    Manufactured Product

    Three Months Ended

    March 31

    ($ per tonne, except as otherwise noted)

    2026

     

    2025

    Sales volumes (tonnes – thousands)

     

     

     

    North America

    1,285

     

    1,312

    Offshore

    2,225

     

    2,090

    Total sales volumes

    3,510

     

    3,402

    Net selling price

     

     

     

    North America

    287

     

    243

    Offshore

    250

     

    204

    Average net selling price

    264

     

    219

    Cost of goods sold

    120

     

    112

    Gross margin

    144

     

    107

    Depreciation and amortization

    50

     

    46

    Gross margin excluding depreciation and amortization1

    194

     

    153

    1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

    • Sales volumes in the first quarter of 2026 were the highest on record, supported by low inventory levels and favorable potash affordability in key offshore markets.
    • Net selling price per tonne increased in the first quarter of 2026 due to higher global benchmark prices.
    • Cost of goods sold per tonne increased in the first quarter of 2026 primarily due to higher depreciation. Controllable cash cost of product manufactured per tonne decreased in the first quarter of 2026 due to higher potash production.

    Supplemental Data

    Three Months Ended

    March 31

     

    2026

     

    2025

    Production volumes (tonnes – thousands)

    3,660

     

    3,289

    Potash controllable cash cost of product manufactured per tonne1

    59

     

    60

    Canpotex sales by market (percentage of sales volumes)2

     

     

     

    Latin America

    41

     

    31

    Other Asian markets3

    30

     

    32

    China

    17

     

    17

    India

    1

     

    4

    Other markets

    11

     

    16

    Total

    100

     

    100

    1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

    2 See Note 8 to the interim financial statements.

    3 All Asian markets except China and India.

    Nitrogen

     

    Three Months Ended

    March 31

    ($ millions, except as otherwise noted)

    2026

     

    20251, 2

    % Change

    Net sales

    1,014

     

    885

     

    15

    Cost of goods sold

    647

     

    598

     

    8

    Gross margin

    367

     

    287

     

    28

    Adjusted EBITDA2

    482

     

    405

     

    19

    1 Comparative figures have been reclassified for our Purchase for Resale business from Nitrogen to the Corporate and Others segment.

    2 See Note 2 to the interim financial statements.

    • Nitrogen adjusted EBITDA increased in the first quarter of 2026 primarily due to higher global benchmarks. Our low-cost North American nitrogen plants delivered an ammonia operating rate2 of 92 percent in the first quarter of 2026, consistent with our planned production and reflective of a continued focus on reliability initiatives.

    Manufactured Product

    Three Months Ended

    March 31

    ($ per tonne, except as otherwise noted)

    2026

     

    2025

    Sales volumes (tonnes – thousands)

     

     

     

    Ammonia

    298

     

    496

    Urea and ESN®

    748

     

    795

    Solutions, nitrates and sulfates

    1,295

     

    1,178

    Total sales volumes

    2,341

     

    2,469

    Net selling price

     

     

     

    Ammonia

    479

     

    418

    Urea and ESN®

    515

     

    438

    Solutions, nitrates and sulfates

    282

     

    236

    Average net selling price

    381

     

    337

    Cost of goods sold

    225

     

    224

    Gross margin

    156

     

    113

    Depreciation and amortization

    65

     

    58

    Gross margin excluding depreciation and amortization1

    221

     

    171

    1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

    • Sales volumes decreased in the first quarter of 2026, reflecting no production from the Trinidad and New Madrid facilities4, partially offset by higher solutions, nitrates and sulfates sales volumes supported by reliability and debottleneck initiatives.
    • Net selling price per tonne was higher in the first quarter of 2026 for all major nitrogen products due to stronger global benchmark prices.
    • Cost of goods sold per tonne was flat in the first quarter of 2026, as lower overall natural gas costs were offset by higher depreciation and other variable costs. The lower overall natural gas cost reflects a higher proportion of production from our low-cost North American nitrogen plants compared to the same period of 2025.

    Supplemental Data

    Three Months Ended

    March 31

     

    2026

     

    2025

    Sales volumes (tonnes – thousands)

     

     

     

    Fertilizer

    1,409

     

    1,389

    Industrial and feed

    932

     

    1,080

    Production volumes (tonnes – thousands)

     

     

     

    Ammonia production – total1

    1,122

     

    1,543

    Ammonia production – adjusted1, 2

    1,019

     

    1,076

    Ammonia operating rate (%)2

    92

     

    98

    Natural gas costs (dollars per MMBtu)

     

     

     

    Overall natural gas cost excluding realized derivative impact

    3.28

     

    3.91

    Realized derivative impact3

    ‐

     

    ‐

    Overall natural gas cost

    3.28

     

    3.91

    1 All figures are provided on a gross production basis in thousands of product tonnes.

    2 Excludes Trinidad and Joffre.

    3 Includes realized derivative impacts recorded as part of cost of goods sold or other income and expenses.

    4 As previously disclosed, on October 23, 2025, the Trinidad nitrogen facility completed a controlled shutdown and we ceased production at our New Madrid nitrogen upgrade facility at year-end 2025.

    Phosphate

     

    Three Months Ended

    March 31

    ($ millions, except as otherwise noted)

    2026

     

    2025

    % Change

    Net sales

    485

     

    360

     

    35

    Cost of goods sold

    489

     

    361

     

    35

    Gross margin

    (4)

     

    (1)

     

    n/m

    Adjusted EBITDA1

    57

     

    61

     

    (7)

    1 See Note 2 to the interim financial statements.

    • Phosphate adjusted EBITDA decreased in the first quarter of 2026 due to higher sulfur input costs, partially offset by higher global benchmarks and sales volumes compared to the same period of 2025.

    Manufactured Product

    Three Months Ended

    March 31

    ($ per tonne, except as otherwise noted)

    2026

     

    2025

    Sales volumes (tonnes – thousands)

     

     

     

    Fertilizer

    468

     

    332

    Industrial and feed

    190

     

    168

    Total sales volumes

    658

     

    500

    Net selling price

     

     

     

    Fertilizer

    668

     

    656

    Industrial and feed

    883

     

    817

    Average net selling price

    730

     

    710

    Cost of goods sold

    726

     

    700

    Gross margin

    4

     

    10

    Depreciation and amortization

    109

     

    144

    Gross margin excluding depreciation and amortization1

    113

     

    154

    1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

    • Sales volumes were higher in the first quarter of 2026 due to higher production volumes from reliability improvements compared to the same period of 2025.
    • Net selling price per tonne increased in the first quarter of 2026 due to stronger global benchmark prices.
    • Cost of goods sold per tonne increased in the first quarter of 2026 primarily due to higher sulfur input costs, more than offsetting higher production volumes that improved cost absorption and lowered depreciation per tonne compared to the same period of 2025.

    Supplemental Data

    Three Months Ended

    March 31

     

    2026

     

    2025

    Production volumes (P2O5 tonnes – thousands)

    337

     

    282

    P2O5 operating rate (%)

    80

    67

     

    Corporate and Others and Eliminations

     

    Three Months Ended

    March 31

    ($ millions, except as otherwise noted)

    2026

     

    20251, 2

     

    % Change

    Corporate and Others

     

     

     

     

     

    Gross margin2

    14

     

    14

     

    ‐

    Selling recovery

    (3)

     

    (3)

     

    ‐

    General and administrative expenses

    111

     

    99

     

    12

    Share-based compensation expense

    116

     

    42

     

    176

    Foreign exchange loss, net of related derivatives

    5

     

    7

     

    (29)

    Other expenses

    10

     

    18

     

    (44)

    Adjusted EBITDA2

    (84)

     

    (78)

     

    8

    Eliminations

     

     

     

     

     

    Gross margin

    (35)

     

    (30)

     

    17

    Adjusted EBITDA2

    (36)

     

    (28)

     

    29

    1 Comparative figures have been reclassified for our Purchase for Resale business from Nitrogen to the Corporate and Others segment.

    2 See Note 2 to the interim financial statements.
    • Share-based compensation expense was higher in the first quarter of 2026 due to an increase in the fair value of our share-based awards. The fair value of our share-based awards takes into consideration several factors, such as our share price movement, our performance relative to our peer group and our return on invested capital.





    Finance Costs, Income Taxes and Other Comprehensive (Loss) Income

     

    Three Months Ended

    March 31

    ($ millions, except as otherwise noted)

    2026

     

    2025

     

    % Change

    Finance costs

    176

     

    179

     

    (2)

    Income taxes

     

     

     

     

     

    Income tax expense

    45

     

    28

     

    61

    Actual effective tax rate including discrete items (%)

    24

     

    60

     

    (60)

    Other comprehensive income

    66

     

    25

     

    164

    • Income tax expense increased in the first quarter of 2026 mainly due to higher earnings. The actual effective tax rate including discrete items decreased due to a change in the proportion of earnings (loss) between tax jurisdictions.





    Liquidity and Capital Resources

    Sources and uses of liquidity

    We continued to manage our capital in accordance with our capital allocation strategy. We believe that our internally generated cash flow, supplemented by available borrowings under new or existing financing sources, if necessary, will be sufficient to meet our anticipated capital expenditures, planned growth and development activities, and other cash requirements for the foreseeable future. Refer to the "Capital Structure and Management" section for details on our existing long-term debt and credit facilities.

    Sources and uses of cash

     

    Three Months Ended

    March 31

    ($ millions, except as otherwise noted)

    2026

     

    2025

     

    % Change

    Cash used in operating activities

    (851)

     

    (1,082)

     

    (21)

    Cash used in investing activities

    (487)

     

    (243)

     

    100

    Cash provided by financing activities

    1,426

     

    1,365

     

    4

    Cash used for dividends and share repurchases1

    (409)

     

    (413)

     

    (1)

    1 This is a supplementary financial measure. See the "Other Financial Measures" section.

     

    Cash used in operating activities

    • Cash used in operating activities in the first quarter of 2026 was lower compared to the same period in 2025 primarily due to higher fertilizer global benchmarks, increased Retail earnings and record Potash sales volumes.

    Cash used in investing activities

    • Cash used in investing activities in the first quarter of 2026 was higher compared to the same period in 2025 due to higher cash used on business acquisitions in 2026. The 2025 comparative period included proceeds from the disposal of our investment in Sinofert Holdings Limited.

    Cash provided by financing activities

    • Cash provided by financing activities in the first quarter of 2026 was higher compared to the same period in 2025 due to higher commercial paper issuances in 2026. Additionally, in 2025, we issued $1.0 billion of senior notes. We had no issuances of senior notes in the first quarter of 2026.

    Cash used for dividends and share repurchases

    • Cash used for dividends and share repurchases was consistent in the first quarter of 2026 compared to the same period in 2025.
     
     

    Financial Condition Review

    The following is a comparison of balance sheet categories that are considered material:

     

    As at

     

     

     

     

    ($ millions, except as otherwise noted)

    March 31, 2026

     

    December 31, 2025

     

    $ Change

     

    % Change

    Assets

     

     

     

     

     

     

     

    Cash and cash equivalents

    777

     

    701

     

    76

     

    11

    Receivables

    6,284

     

    5,675

     

    609

     

    11

    Inventories

    8,681

     

    6,977

     

    1,704

     

    24

    Prepaid expenses and other current assets

    733

     

    1,396

     

    (663)

     

    (47)

    Property, plant and equipment

    22,659

     

    22,747

     

    (88)

     

    ‐

    Liabilities and Shareholders' Equity

     

     

     

     

     

     

     

    Short-term debt

    2,766

     

    873

     

    1,893

     

    217

    Trade, other payables and accrued liabilities

    9,137

     

    9,309

     

    (172)

     

    (2)

    Long-term debt, including current portion

    9,861

     

    9,863

     

    (2)

     

    ‐

    Share capital

    13,515

     

    13,519

     

    (4)

     

    ‐

    Retained earnings

    11,853

     

    12,076

     

    (223)

     

    (2)

    • Explanations for changes in Cash and cash equivalents are in the "Liquidity and Capital Resources - Sources and uses of cash" section.
    • Receivables increased due to higher fertilizer global benchmarks and the seasonality of our Retail segment, resulting in higher receivables with customers and vendor rebates, partially offset by improved collection of receivables in North America. Receivables also increased from record Potash sales volumes.
    • Inventories increased due to the seasonality of our Retail segment. Our North American inventory levels generally increase at year-end, peak in the first quarter of the year in preparation for the planting and application seasons, and are drawn down in the succeeding quarters.
    • Prepaid expenses and other current assets decreased due to Retail taking delivery of prepaid inventories in preparation for the spring planting and applications season in North America.
    • Short-term debt increased due to higher commercial paper issuances to support working capital requirements driven by the seasonality of our business.
    • Trade, other payables and accrued liabilities decreased due to the settlement in the first quarter of 2026 of our Retail supplier financing arrangement obligations that were entered into in the fourth quarter of 2025. This was partially offset by higher Retail customer prepayments received in the first quarter of 2026 in anticipation of crop input price increases.





    Capital Structure and Management

    Principal debt instruments

    As part of the normal course of business, we closely monitor our liquidity position. We use a combination of cash generated from operations and short-term and long-term debt to finance our operations. We continually evaluate various financing arrangements and may seek to engage in transactions from time to time when market and other conditions are favorable. We were in compliance with our debt covenants and did not have any changes to our credit ratings for the three months ended March 31, 2026.

    Capital structure (debt and equity)

    ($ millions)

    March 31, 2026

     

    December 31, 2025

    Short-term debt

    2,766

     

    873

    Current portion of long-term debt

    1,036

     

    513

    Current portion of lease liabilities

    362

     

    346

    Long-term debt

    8,825

     

    9,350

    Lease liabilities

    957

     

    937

    Shareholders' equity

    25,192

     

    25,365

     

    Commercial paper, credit facilities and other debt

    We have a total facility limit of approximately $7,426 million comprised of several credit facilities available in the jurisdictions where we operate. In North America, we have a commercial paper program, which is limited to the undrawn amount under our $4,500 million unsecured revolving term credit facility and excess cash invested in highly liquid securities.

    As at March 31, 2026, we utilized $2,780 million of our total facility limit, which includes $2,421 million of commercial paper outstanding. In the first quarter of 2026, we extended the maturity of our accounts receivable purchase facility from March 6, 2026 to March 31, 2028 and entered into a $69 million uncommitted revolving demand facility.

    As at March 31, 2026, $234 million in letters of credit were outstanding and committed, with $352 million of remaining credit available under our letter of credit facilities.

    Our long-term debt consists primarily of notes and debentures. See the "Capital Structure and Management" section of our 2025 Annual Report for information on balances, rates and maturities for our notes and debentures.

    Outstanding share data

     

    As at May 5, 2026

    Common shares

    480,023,548

    Options to purchase common shares

    1,921,277

    For more information on our capital management, see Note 4 to the annual financial statements in our 2025 Annual Report.





    Quarterly Results

    ($ millions, except as otherwise noted)

    Q1 2026

    Q4 2025

    Q3 2025

    Q2 2025

    Q1 2025

    Q4 2024

    Q3 2024

    Q2 2024

    Sales

    6,046

     

    5,340

     

    6,007

     

    10,438

     

    5,100

     

    5,079

     

    5,348

     

    10,156

    Net earnings

    139

     

    580

     

    469

     

    1,229

     

    19

     

    118

     

    25

     

    392

    Net earnings attributable to equity holders of Nutrien

    131

     

    571

     

    464

     

    1,221

     

    11

     

    113

     

    18

     

    385

    Net earnings per share attributable to equity holders of Nutrien

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Basic

    0.27

     

    1.18

     

    0.96

     

    2.51

     

    0.02

     

    0.23

     

    0.04

     

    0.78

    Diluted

    0.27

     

    1.18

     

    0.96

     

    2.50

     

    0.02

     

    0.23

     

    0.04

     

    0.78

    Our quarterly earnings are significantly affected by the seasonality of our business, fertilizer benchmark prices, global demand-supply conditions, grower affordability and weather. See Note 2 to the interim financial statements.





    Accounting Policies and New IFRS Standards

    Significant accounting policies are disclosed in our 2025 Annual Report and have been consistently applied for the three months ended March 31, 2026, except as described below.

    Amendments to IFRS 9 and IFRS 7, Amendments to the Classification and Measurement of Financial Instruments

    Amendments to IFRS 9 and IFRS 7, Amendments to the Classification and Measurement of Financial Instruments, were adopted effective January 1, 2026, the required adoption date. The impact was not material. On initial adoption, there was an adjustment of $(13) million to opening cash and cash equivalents as at January 1, 2026, which has been reflected in the condensed consolidated statement of cash flows for the three months ended March 31, 2026.





    Critical Accounting Estimates

    The preparation of financial statements in accordance with IFRS requires management to make estimates and judgments that affect reported assets, liabilities, revenues and expenses. We have discussed the development, selection and application of our key accounting policies, and the critical accounting estimates and assumptions they involve, with the Audit Committee of the Board.

    Our critical accounting estimates are discussed on pages 64 to 65 of our 2025 Annual Report. There were no material changes to our critical accounting estimates for the three months ended March 31, 2026.





    Controls and Procedures

    Management is responsible for establishing and maintaining adequate internal control over financial reporting ("ICFR"), as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended, and National Instrument 52-109 Certification of Disclosure in Issuers' Annual and Interim Filings. ICFR is designed to provide reasonable assurance regarding the reliability of financial reporting and preparation of financial statements for external purposes in accordance with IFRS. Any system of ICFR, no matter how well designed, has inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.

    There has been no change in our ICFR during the three months ended March 31, 2026, that has materially affected, or is reasonably likely to materially affect, our ICFR.





    Forward-Looking Statements

    Certain statements and other information included in this document, including within the "Market Outlook and Guidance" section, constitute "forward-looking information" or "forward-looking statements" (collectively, "forward-looking statements") under applicable securities laws (such statements are often accompanied by words such as "anticipate", "forecast", "expect", "believe", "may", "will", "should", "estimate", "project", "intend" or other similar words). All statements in this document, other than those relating to historical information or current conditions, are forward-looking statements, including, but not limited to: Nutrien's business strategies, plans, prospects and opportunities; Nutrien's 2026 full-year guidance, including expectations regarding Retail adjusted EBITDA, Potash sales volumes, Nitrogen sales volumes, Phosphate sales volumes, depreciation and amortization, finance costs, effective tax rate on adjusted net earnings and capital expenditures, including the assumptions and expectations stated therein; expectations regarding the review of strategic alternatives for our Phosphate business, Trinidad Nitrogen facility and Brazilian Retail business and associated outcomes; expectations regarding structural growth in our downstream business; expectations regarding our capital allocation approach and strategies, including our intentions with respect to our strategic actions and the expected timing thereof; our expectations regarding Nutrien's strategic priorities and our ability to advance and achieve such strategic priorities in 2026 and beyond; expectations regarding various performance targets in 2026 and beyond and our ability to achieve such targets; capital spending expectations for 2026 and beyond; expectations regarding performance of our operating segments in 2026 and beyond; the expectation that internally generated cash flow, supplemented by available borrowings, if necessary, will be sufficient to meet our anticipated capital expenditures, planned growth and development activities, and other cash requirements; expectations regarding payment of dividends and share repurchases; our operating segment market outlooks and our expectations for market conditions and fundamentals, and the anticipated supply and demand for our products and services, crop input demand, expected market, industry and growing conditions with respect to crop nutrient application rates, planted acres, farmer crop investment, crop mix and the need to replenish soil nutrient levels, input costs, production volumes and expenses, shipments, natural gas costs and availability, consumption, prices, operating rates, the impact of seasonality, import and export volumes, tariffs, trade or export restrictions, economic sanctions and restrictions, geopolitical disruptions, including the ongoing conflict in the Middle East, inventories, crop development, and natural gas curtailments; the negotiation of sales contracts; acquisitions and divestitures and the anticipated benefits thereof; and expectations in connection with our ability to generate free cash flow, enhance earnings quality, and deliver long-term returns to shareholders.

    These forward-looking statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from such forward-looking statements. As such, undue reliance should not be placed on these forward-looking statements.

    All of the forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions referred to below and elsewhere in this document. Although we believe that these assumptions are reasonable, having regard to our experience and our perception of historical trends, this list is not exhaustive of the factors that may affect any of the forward-looking statements and the reader should not place undue reliance on these assumptions and such forward-looking statements. Current conditions, economic and otherwise, render assumptions, although reasonable when made, subject to greater uncertainty.

    The additional key assumptions that have been made in relation to the operation of our business as currently planned and our ability to achieve our business objectives include, among other things, assumptions with respect to: our ability to successfully implement our business strategies, growth and capital allocation investments and initiatives; that we will conduct our operations and achieve results of operations as anticipated; growth in crop nutrient sales volumes and gross margins; our ability to successfully complete, integrate and realize the anticipated benefits of our already completed and future acquisitions and divestitures, and that we will be able to implement our standards, controls, procedures and policies in respect of any acquired businesses and realize the expected synergies on the anticipated timeline or at all; increased proprietary products gross margin; successful execution of the review of strategic alternatives for our Phosphate business, Trinidad Nitrogen facility and Brazilian Retail business, within the anticipated timing and parameters, and realization of the expected benefits therefrom; continued reliability improvements; that future business, regulatory and industry conditions will be within the parameters expected by us, including with respect to prices, expenses, margins, operating rates, demand, supply, product availability, shipments, consumption, weather conditions, supplier agreements, product distribution agreements, inventory levels, exports, tariffs, including general or retaliatory tariffs, trade restrictions, international trade arrangements, government support, crop development and cost of labor and interest, exchange and effective tax rates; global economic conditions and the accuracy of our market outlook expectations for 2026 and in the future; assumptions related to our assessment of recoverable amount estimates of our assets; our intention to complete share repurchases under our normal course issuer bid programs, the funding of such share repurchases, existing and future market conditions, including with respect to the price of our common shares, capital allocation priorities and compliance with respect to applicable limitations under securities laws and regulations and stock exchange policies and assumptions related to our ability to fund our dividends at the current level; our expectations regarding the impacts, direct and indirect, of certain geopolitical conflicts, including the ongoing conflict in the Middle East, on, among other things, global supply and demand, including for crop nutrients, energy and commodity prices, global interest rates, supply chains and the global macroeconomic environment, including inflation; the adequacy of our cash generated from operations and our ability to access our credit facilities or capital markets for additional sources of financing; our ability to identify suitable candidates for acquisitions and divestitures and negotiate acceptable terms; the availability of investment opportunities that align with our strategic priorities and growth strategy; our ability to maintain investment grade ratings and achieve our performance targets; and our ability to successfully negotiate sales and other contracts and our ability to successfully implement new initiatives and programs.

    Events or circumstances that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to: general global economic, market and business conditions; failure to achieve expected results of our business strategy, capital allocation initiatives, results of operations or targets; failure to complete announced and future strategic and asset optimization initiatives, acquisitions or divestitures at all or on the expected terms and within the expected timeline; seasonality of our business; climate change and weather conditions, including impacts from regional flooding and/or drought conditions; crop planted acreage, yield and prices; the supply and demand and price levels for our products; governmental and regulatory requirements and actions by governmental authorities, including changes in government policy (including general or retaliatory tariffs, trade restrictions, or other changes to international trade arrangements) and regulatory investigations; current and future litigation proceedings; the results of our review of strategic alternatives for our Phosphate business, Trinidad Nitrogen facility and Brazilian Retail business, including the process and the timing thereof, and whether the review will result in Nutrien undertaking a transaction, including the terms and timing relating thereto, the completion thereof and the benefits to be realized therefrom; the effects of current and future multinational trade agreements or other developments affecting the level of trade or export restrictions; government ownership requirements, changes in environmental, tax, antitrust and other laws or regulations and the interpretation thereof; political or military risks, including civil unrest, actions by armed groups or conflict and malicious acts, including terrorism and industrial espionage; our ability to access sufficient, cost-effective and timely transportation, distribution and storage of products (including potential rail transportation and port disruptions due to labor strikes and/or work stoppages or other similar actions); the occurrence of a major environmental or safety incident or becoming subject to legal or regulatory proceedings; innovation and cybersecurity risks related to our systems, including our costs of addressing or mitigating such risks; counterparty and sovereign risk; delays in completion of turnarounds at our major facilities or challenges related to our major facilities that are out of our control; interruptions of or constraints in availability of key inputs, including natural gas and sulfur; any significant impairment of the carrying amount of certain assets; the risk that rising interest rates and/or deteriorated business operating results may result in the further impairment of assets or goodwill attributed to certain of our cash generating units; risks related to reputational loss; certain complications that may arise in our mining processes; the ability to attract, engage and retain skilled employees and strikes or other forms of work stoppages; geopolitical conflicts, including the ongoing conflict in the Middle East, and their potential impact on, among other things, global market conditions and supply and demand, including for crop nutrients, energy and commodity prices, interest rates, supply chains and the global economy generally; our ability to execute on our strategies related to environmental, social and governance matters, and achieve related expectations, targets and commitments, including risks associated with disclosure thereof; and other risk factors detailed from time to time in Nutrien reports filed with the Canadian securities regulators and the SEC.

    The purpose of our Retail adjusted EBITDA, depreciation and amortization, finance costs, effective tax rate and capital expenditures guidance ranges are to assist readers in understanding our expected and targeted financial results, and this information may not be appropriate for other purposes.

    The forward-looking statements in this document are made as of the date hereof and Nutrien disclaims any intention or obligation to update or revise any forward-looking statements in this document as a result of new information or future events, except as may be required under applicable Canadian securities legislation or applicable US federal securities laws.





    Terms and Definitions

    For the definitions of certain financial and non-financial terms used in this document, as well as a list of abbreviated company names and sources, see the "Terms and definitions" section of our 2025 Annual Report. All references to per share amounts pertain to diluted net earnings (loss) per share, "n/m" indicates information that is not meaningful, and all financial amounts are stated in millions of US dollars, unless otherwise noted.





    About Nutrien

    Nutrien is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve farmers. Our vision is to be the leading global agricultural solutions provider, delivering superior shareholder value through safe and sustainable operations. To achieve this vision, our strategy is anchored in three priorities: simplify and focus, operational excellence and a disciplined and intentional approach to capital allocation. This strategy is designed to create low-risk, structural free cash flow growth by leveraging our core competencies and to deliver reliable, growing cash returns to shareholders.

    More information about Nutrien can be found at www.nutrien.com.

    Selected financial data for download can be found in our data tool at https://www.nutrien.com/investors/interactive-data-tool

    Such data is not incorporated by reference herein.

    Nutrien will host a Conference Call on Thursday, May 7, 2026 at 10:00 a.m. Eastern Time.

    Telephone conference dial-in numbers:

    • From Canada and the US: 1-800-990-2777
    • International: 1-416-855-9085
    • Conference ID: 89180. Please dial in 15 minutes prior to ensure you are placed on the call in a timely manner.

    Live Audio Webcast: Visit https://www.nutrien.com/news/events/2026-q1-earnings-conference-call





    Non-GAAP Financial Measures

    We use both IFRS measures and certain non-GAAP financial measures to assess performance. Non-GAAP financial measures are financial measures disclosed by the Company that: (a) depict historical or expected future financial performance, financial position or cash flow of the Company; (b) with respect to their composition, exclude amounts that are included in, or include amounts that are excluded from, the composition of the most directly comparable financial measure disclosed in the primary financial statements of the Company; (c) are not disclosed in the financial statements of the Company; and (d) are not a ratio, fraction, percentage or similar representation. Non-GAAP ratios are financial measures disclosed by the Company that are in the form of a ratio, fraction, percentage or similar representation that has a non-GAAP financial measure as one or more of its components, and that are not disclosed in the financial statements of the Company.

    These non-GAAP financial measures and non-GAAP ratios are not standardized financial measures under IFRS and, therefore, are unlikely to be comparable to similar financial measures presented by other companies. Management believes these non-GAAP financial measures and non-GAAP ratios provide transparent and useful supplemental information to help investors evaluate our financial performance, financial condition and liquidity using the same measures as management. These non-GAAP financial measures and non-GAAP ratios should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with IFRS.

    The following section outlines our non-GAAP financial measures and non-GAAP ratios, their compositions, and why management uses each measure. It also includes reconciliations to the most directly comparable IFRS measures. Except as otherwise described herein, our non-GAAP financial measures and non-GAAP ratios are calculated on a consistent basis from period to period and are adjusted for specific items in each period, as applicable. As additional non-recurring or unusual items arise in the future, we generally exclude these items in our calculations.

    Adjusted EBITDA (Consolidated)

    Most directly comparable IFRS financial measure: Net earnings (loss).

    Definition: Adjusted EBITDA is calculated as net earnings (loss) before finance costs, income taxes, depreciation and amortization, share-based compensation and foreign exchange gain/loss (net of related derivatives). We also adjust this measure for the following other income and expenses that are excluded when management evaluates the performance of our day-to-day operations: certain integration and restructuring related costs, impairment or reversal of impairment of assets, gain or loss on sale of certain businesses and investments, asset retirement obligations ("ARO") and accrued environmental costs ("ERL") related to our non-operating sites, and loss related to financial instruments in Argentina.

    Why we use the measure and why it is useful to investors: It is not impacted by long-term investment and financing decisions, but rather focuses on the performance of our day-to-day operations. It provides a measure of our ability to service debt and to meet other payment obligations and as a component of employee remuneration calculations.

     

    Three Months Ended

    March 31

    ($ millions)

    2026

     

    2025

    Net earnings

    139

     

    19

    Finance costs

    176

     

    179

    Income tax expense

    45

     

    28

    Depreciation and amortization

    606

     

    571

    EBITDA1

    966

     

    797

    Adjustments:

     

     

     

    Share-based compensation expense

    116

     

    42

    Foreign exchange loss, net of related derivatives

    5

     

    7

    ARO/ERL related (income) expenses for non-operating sites

    (28)

     

    5

    Restructuring costs

    16

     

    1

    Impairment of assets recorded in other income and expenses

    30

     

    ‐

    Adjusted EBITDA

    1,105

     

    852

    1 EBITDA is calculated as net earnings before finance costs, income taxes, and depreciation and amortization.

     

    Adjusted Net Earnings and Adjusted Net Earnings Per Share

    Most directly comparable IFRS financial measure: Net earnings (loss) and diluted net earnings (loss) per share.

    Definition: Adjusted net earnings and related per share information are calculated as net earnings (loss) before share-based compensation and foreign exchange gain/loss (net of related derivatives), net of tax. We also adjust this measure for the following other income and expenses (net of tax) that are excluded when management evaluates the performance of our day-to-day operations: certain integration and restructuring related costs, impairment or reversal of impairment of assets, gain or loss on sale of certain businesses and investments, gain or loss on early extinguishment of debt or on settlement of derivatives due to discontinuance of hedge accounting, asset retirement obligations and accrued environmental costs related to our non-operating sites, loss related to financial instruments in Argentina, change in recognition of tax losses and deductible temporary differences related to impairments and certain changes to tax declarations. We generally apply the annual forecasted effective tax rate to specific adjustments during the year, and at year-end, we apply the actual effective tax rate.

    Why we use the measure and why it is useful to investors: Focuses on the performance of our day-to-day operations and is used as a component of employee remuneration calculations.

     

    Three Months Ended

    March 31, 2026

     

     

     

     

     

    Per

     

    Increases

     

     

     

    Diluted

    ($ millions, except as otherwise noted)

    (Decreases)

     

    Post-Tax

     

    Share

    Net earnings attributable to equity holders of Nutrien

     

     

    131

     

    0.27

    Adjustments:

     

     

     

     

     

    Share-based compensation expense

    116

     

    88

     

    0.18

    Foreign exchange loss, net of related derivatives

    5

     

    10

     

    0.02

    Restructuring costs

    16

     

    16

     

    0.03

    Impairment of assets recorded in other income and expenses

    30

     

    22

     

    0.05

    ARO/ERL related (income) for non-operating sites

    (28)

     

    (22)

     

    (0.04)

    Sub-total adjustments

    139

     

    114

     

    0.24

    Adjusted net earnings

     

     

    245

     

    0.51

     

     

    Three Months Ended

    March 31, 2025

     

     

     

     

     

    Per

     

    Increases

     

     

     

    Diluted

    ($ millions, except as otherwise noted)

    (Decreases)

     

    Post-Tax

     

    Share

    Net earnings attributable to equity holders of Nutrien

     

     

    11

     

    0.02

    Adjustments:

     

     

     

     

     

    Share-based compensation expense

    42

     

    31

     

    0.06

    Foreign exchange loss, net of related derivatives

    7

     

    6

     

    0.01

    Restructuring costs

    1

     

    1

     

    ‐

    ARO/ERL related expenses for non-operating sites

    5

     

    4

     

    0.02

    Sub-total adjustments

    55

     

    42

     

    0.09

    Adjusted net earnings

     

     

    53

     

    0.11

     

    Effective Tax Rate on Adjusted Net Earnings

    Effective tax rate on adjusted net earnings guidance is a forward-looking non-GAAP financial measure as it includes adjusted net earnings, which is a non-GAAP financial measure. It is provided to assist readers in understanding our expected financial results. Effective tax rate on adjusted net earnings guidance excludes certain items that management is aware of that permit management to focus on the performance of our operations (see the Adjusted Net Earnings and Adjusted Net Earnings Per Share section for items generally adjusted). We do not provide a reconciliation of this forward-looking measure to the most directly comparable financial measures calculated and presented in accordance with IFRS because a meaningful or accurate calculation of reconciling items and the information is not available without unreasonable effort due to unknown variables, including the timing and amount of certain reconciling items, and the uncertainty related to future results. These unknown variables may include unpredictable transactions of significant value that may be inherently difficult to determine without unreasonable efforts. The probable significance of such unavailable information, which could be material to future results, cannot be addressed.

    Gross Margin Excluding Depreciation and Amortization Per Tonne – Manufactured Product

    Most directly comparable IFRS financial measure: Gross margin.

    Definition: Gross margin per tonne less depreciation and amortization per tonne for manufactured products. Reconciliations are provided in the "Segment Results" section.

    Why we use the measure and why it is useful to investors: Focuses on the performance of our day-to-day operations, which excludes the effects of items that primarily reflect the impact of long-term investment and financing decisions.

    Potash Controllable Cash Cost of Product Manufactured ("COPM") Per Tonne

    Most directly comparable IFRS financial measure: Cost of goods sold ("COGS") for the Potash segment.

    Definition: Total Potash COGS excluding depreciation and amortization expense included in COPM, royalties, natural gas costs and carbon taxes, change in inventory, and other adjustments, divided by potash production tonnes.

    Why we use the measure and why it is useful to investors: To assess operational performance. Potash controllable cash COPM excludes the effects of production from other periods and the impacts of our long-term investment decisions, supporting a focus on the performance of our day-to-day operations. Potash controllable cash COPM also excludes royalties and natural gas costs and carbon taxes, which management does not consider controllable, as they are primarily driven by regulatory and market conditions.

     

    Three Months Ended

    March 31

    ($ millions, except as otherwise noted)

    2026

     

    2025

    Total COGS – Potash

    422

     

    380

    Change in inventory

    8

     

    7

    Other adjustments1

    (5)

     

    (13)

    COPM

    425

     

    374

    Depreciation and amortization in COPM

    (171)

     

    (145)

    Royalties in COPM

    (26)

     

    (19)

    Natural gas costs and carbon taxes in COPM

    (13)

     

    (12)

    Controllable cash COPM

    215

     

    198

    Production volumes (tonnes – thousands)

    3,660

     

    3,289

    Potash controllable cash COPM per tonne

    59

     

    60

    1 Other adjustments include unallocated production overhead that is recognized as part of cost of goods sold but is not included in the measurement of inventory and changes in inventory balances.

    Retail Cash Operating Coverage Ratio

    Definition: Retail selling, general and administrative, and other expenses (income), excluding depreciation and amortization expense, divided by Retail gross margin excluding depreciation and amortization expense in cost of goods sold, for the last four rolling quarters.

    Why we use the measure and why it is useful to investors: To understand the costs and underlying economics of our Retail operations and to assess our Retail operating performance and ability to generate cash flow.

     

    Rolling Four Quarters Ended March 31, 2026

    ($ millions, except as otherwise noted)

    Q2 2025

     

    Q3 2025

     

    Q4 2025

     

    Q1 2026

     

    Total

    Selling expenses

    948

     

    792

     

    811

     

    798

     

    3,349

    General and administrative expenses

    44

     

    44

     

    40

     

    44

     

    172

    Other expenses

    54

     

    40

     

    4

     

    36

     

    134

    Operating expenses

    1,046

     

    876

     

    855

     

    878

     

    3,655

    Depreciation and amortization in operating expenses

    (172)

     

    (179)

     

    (184)

     

    (179)

     

    (714)

    Operating expenses excluding depreciation and amortization

    874

     

    697

     

    671

     

    699

     

    2,941

     

     

     

     

     

     

     

     

     

     

    Gross margin

    2,018

     

    922

     

    977

     

    800

     

    4,717

    Depreciation and amortization in cost of goods sold

    5

     

    5

     

    5

     

    5

     

    20

    Gross margin excluding depreciation and amortization

    2,023

     

    927

     

    982

     

    805

     

    4,737

    Cash operating coverage ratio (%)

     

     

     

     

     

     

     

     

    62

     

     

     

     

     

     

     

     

     

     

     

    Rolling Four Quarters Ended December 31, 2025

    ($ millions, except as otherwise noted)

    Q1 2025

     

    Q2 2025

     

    Q3 2025

     

    Q4 2025

     

    Total

    Selling expenses

    755

     

    948

     

    792

     

    811

     

    3,306

    General and administrative expenses

    44

     

    44

     

    44

     

    40

     

    172

    Other expenses

    25

     

    54

     

    40

     

    4

     

    123

    Operating expenses

    824

     

    1,046

     

    876

     

    855

     

    3,601

    Depreciation and amortization in operating expenses

    (179)

     

    (172)

     

    (179)

     

    (184)

     

    (714)

    Operating expenses excluding depreciation and amortization

    645

     

    874

     

    697

     

    671

     

    2,887

     

     

     

     

     

     

     

     

     

     

    Gross margin

    686

     

    2,018

     

    922

     

    977

     

    4,603

    Depreciation and amortization in cost of goods sold

    5

     

    5

     

    5

     

    5

     

    20

    Gross margin excluding depreciation and amortization

    691

     

    2,023

     

    927

     

    982

     

    4,623

    Cash operating coverage ratio (%)

     

     

     

     

     

     

     

     

    62

     

    Retail Average Working Capital to Sales

    Definition: Retail average working capital divided by Retail sales for the last four rolling quarters.

    Why we use the measure and why it is useful to investors: To evaluate operational efficiency. A lower or higher percentage represents increased or decreased efficiency, respectively.

     

    Rolling Four Quarters Ended March 31, 2026

    ($ millions, except as otherwise noted)

    Q2 2025

     

    Q3 2025

     

    Q4 2025

     

    Q1 2026

     

     

    Average/Total

    Current assets

    11,442

     

    10,823

     

    11,185

     

    12,558

     

     

     

    Current liabilities

    (8,051)

     

    (5,348)

     

    (8,275)

     

    (7,799)

     

     

     

    Working capital

    3,391

     

    5,475

     

    2,910

     

    4,759

     

     

    4,134

     

     

     

     

     

     

     

     

     

     

     

    Sales

    7,959

     

    3,427

     

    3,144

     

    3,640

     

     

    18,170

    Average working capital to sales (%)

     

     

     

     

     

     

     

     

     

    23

     

     

     

     

     

     

     

     

     

     

     

     

    Rolling Four Quarters Ended December 31, 2025

    ($ millions, except as otherwise noted)

    Q1 2025

     

    Q2 2025

     

    Q3 2025

     

    Q4 2025

     

     

    Average/Total

    Current assets

    11,510

     

    11,442

     

    10,823

     

    11,185

     

     

     

    Current liabilities

    (7,561)

     

    (8,051)

     

    (5,348)

     

    (8,275)

     

     

     

    Working capital

    3,949

     

    3,391

     

    5,475

     

    2,910

     

     

    3,931

     

     

     

     

     

     

     

     

     

     

     

    Sales

    3,090

     

    7,959

     

    3,427

     

    3,144

     

     

    17,620

    Average working capital to sales (%)

     

     

     

     

     

     

     

     

     

    22

       
       

    Other Financial Measures

    Selected Additional Financial Data

    Nutrien Financial Aging

    As at March 31, 2026

    As at

    December 31, 2025

    ($ millions)

    Current

    <31 Days

    past due

    31–90 Days

    past due

    >90 Days

    past due

    Gross receivables

    Allowance1

     

    Net receivables2

    Net

    receivables

    North America

    1,566

    89

    223

    196

    2,074

    (55)

     

    2,019

    2,332

    International

    879

    64

    53

    26

    1,022

    (6)

     

    1,016

    774

    Nutrien Financial

    receivables

    2,445

    153

    276

    222

    3,096

    (61)

     

    3,035

    3,106

    1 Bad debt expense on the above receivables for the three months ended March 31, 2026 was $9 million, in the Retail segment.

    2 In 2026, we assume a debt-to-equity ratio of 9:1 (2025 – 9:1) in funding Nutrien Financial receivables, based on the underlying credit quality of the assets.

       

    Nutrien Financial Net Receivables

    Rolling Four Quarters Ended March 31, 2026

    ($ millions, except as otherwise noted)

    Q2 2025

     

    Q3 2025

     

    Q4 2025

     

    Q1 2026

     

     

    Average/Total

    Average Nutrien Financial net receivables

    4,645

     

    4,452

     

    3,106

     

    3,035

     

     

    3,810

       

    Supplementary Financial Measures

    Supplementary financial measures are financial measures disclosed by the Company that (a) are, or are intended to be, disclosed on a periodic basis to depict the historical or expected future financial performance, financial position or cash flow of the Company, (b) are not disclosed in the financial statements of the Company, (c) are not non-GAAP financial measures, and (d) are not non-GAAP ratios.

    The following section provides an explanation of the composition of those supplementary financial measures, if not previously provided.

    Sustaining capital expenditures: Represents capital expenditures that are required to sustain operations at existing levels and include major repairs and maintenance and plant turnarounds.

    Investing capital expenditures: Represents capital expenditures related to significant expansions of current operations or to create cost savings (synergies). Investing capital expenditures exclude capital outlays for business acquisitions and equity-accounted investees.

    Mine development and pre-stripping capital expenditures: Represents capital expenditures that are required for activities to open new areas underground and/or develop a mine or ore body to allow for future production mining and activities required to prepare and/or access the ore, i.e., removal of an overburden that allows access to the ore.

    Cash used for dividends and share repurchases: Calculated as dividends paid to Nutrien's shareholders plus repurchase of common shares as reflected in the unaudited condensed consolidated statements of cash flows. This measure is useful as it represents return of cash to shareholders.





    Condensed Consolidated Financial Statements

    Unaudited

    Condensed Consolidated Statements of Earnings

     

     

    Three Months Ended

     

     

    March 31

    ($ millions, except as otherwise noted)

    Note

    2026

     

    2025

    Sales

    2, 8

    6,046

     

    5,100

    Freight, transportation and distribution

     

    244

     

    226

    Cost of goods sold

     

    4,156

     

    3,554

    Gross Margin

     

    1,646

     

    1,320

    Selling expenses

     

    799

     

    757

    General and administrative expenses

     

    164

     

    152

    Provincial mining taxes

     

    90

     

    68

    Share-based compensation expense

     

    116

     

    42

    Foreign exchange loss, net of related derivatives

     

    3

     

    7

    Other expenses

    3

    114

     

    68

    Earnings Before Finance Costs and Income Taxes

    360

     

    226

    Finance costs

     

    176

     

    179

    Earnings Before Income Taxes

     

    184

     

    47

    Income tax expense

    4

    45

     

    28

    Net Earnings

     

    139

     

    19

    Attributable to

     

     

     

     

    Equity holders of Nutrien

     

    131

     

    11

    Non-controlling interest

     

    8

     

    8

    Net Earnings

     

    139

     

    19

     

     

     

     

     

    Net Earnings Per Share Attributable to Equity Holders of Nutrien ("EPS")

    Basic

     

    0.27

     

    0.02

    Diluted

     

    0.27

     

    0.02

    Weighted average shares outstanding for basic EPS

     

    481,260,000

     

    489,397,000

    Weighted average shares outstanding for diluted EPS

     

    481,647,000

     

    489,540,000

     

     

     

     

     

    (See Notes to the Condensed Consolidated Financial Statements)

    Condensed Consolidated Statements of Comprehensive Income

     

    Three Months Ended

     

    March 31

    ($ millions, net of related income taxes)

    2026

     

    2025

    Net Earnings

    139

     

    19

    Other comprehensive income

     

     

     

    Items that will not be reclassified to net earnings:

     

     

     

    Net fair value loss on investments

    ‐

     

    (18)

    Items that have been or may be subsequently reclassified to net earnings:

     

     

     

    Gain on currency translation of foreign operations

    72

     

    39

    Other

    (6)

     

    4

    Other Comprehensive Income

    66

     

    25

    Comprehensive Income

    205

     

    44

    Attributable to

     

     

     

    Equity holders of Nutrien

    196

     

    36

    Non-controlling interest

    9

     

    8

    Comprehensive Income

    205

     

    44

     

     

     

     

    (See Notes to the Condensed Consolidated Financial Statements)

    Condensed Consolidated Statements of Cash Flows

     

     

    Three Months Ended

     

     

    March 31

    ($ millions)

    Note

    2026

     

    2025

    Operating Activities

     

     

     

     

    Net earnings

     

    139

     

    19

    Adjustments for:

     

     

     

     

    Depreciation and amortization

     

    606

     

    571

    Share-based compensation expense

     

    116

     

    42

    Provision for deferred income tax

     

    41

     

    80

    Net undistributed earnings of equity-accounted investees

     

    (1)

     

    (5)

    Long-term income tax receivables and payables

     

    (15)

     

    (38)

    Other long-term assets, liabilities and miscellaneous

     

    27

     

    5

    Cash from operations before working capital changes

     

    913

     

    674

    Changes in non-cash operating working capital:

     

     

     

     

    Receivables

     

    (530)

     

    (143)

    Inventories and prepaid expenses and other current assets

     

    (991)

     

    (1,274)

    Trade, other payables and accrued liabilities

     

    (243)

     

    (339)

    Cash Used in Operating Activities

     

    (851)

     

    (1,082)

    Investing Activities

     

     

     

     

    Capital expenditures1

     

    (325)

     

    (300)

    Business acquisitions, net of cash acquired

     

    (50)

     

    (11)

    Purchase of investments, held within three months, net

     

    (8)

     

    (16)

    Purchase of investments

     

    ‐

     

    (2)

    Proceeds from sale of investments

     

    ‐

     

    183

    Net changes in non-cash working capital

     

    (94)

     

    (88)

    Other

     

    (10)

     

    (9)

    Cash Used in Investing Activities

     

    (487)

     

    (243)

    Financing Activities

     

     

     

     

    Proceeds from debt, maturing within three months, net

     

    1,921

     

    912

    Proceeds from debt

    ‐

     

    998

    Repayment of debt

    (9)

     

    (4)

    Repayment of principal portion of lease liabilities

     

    (100)

     

    (110)

    Dividends paid to Nutrien's shareholders

    7

    (262)

     

    (265)

    Repurchase of common shares

    7

    (147)

     

    (148)

    Issuance of common shares

     

    45

     

    3

    Other

     

    (22)

     

    (21)

    Cash Provided by Financing Activities

     

    1,426

     

    1,365

    Effect of Exchange Rate Changes on Cash and Cash Equivalents

     

    1

     

    2

    Increase in Cash and Cash Equivalents

     

    89

     

    42

    January 1, 2026 opening balance prior to restatement for amendments to IFRS 9

    9

    701

     

    ‐

    Adjustment on initial application of amendments to IFRS 9 on January 1, 2026

    9

    (13)

     

    ‐

    Cash and Cash Equivalents – Beginning of Period

     

    688

     

    853

    Cash and Cash Equivalents – End of Period

     

    777

     

    895

    Cash and cash equivalents is composed of:

     

     

     

     

    Cash

     

    712

     

    828

    Short-term investments

     

    65

     

    67

     

     

    777

     

    895

    Supplemental Cash Flows Information

     

     

     

     

    Interest paid

     

    148

     

    132

    Income taxes paid

     

    37

     

    7

    Total cash outflow for leases

     

    137

     

    150

    1 Includes additions to property, plant and equipment, and intangible assets for the three months ended March 31, 2026 of $299 million and $26 million (2025 – $279 million and $21 million).

     

    (See Notes to the Condensed Consolidated Financial Statements)

    Condensed Consolidated Statements of Changes in Shareholders' Equity

     

     

     

     

     

     

     

    Accumulated other comprehensive

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    (loss) income ("AOCI")

     

     

     

     

     

     

     

    ($ millions, inclusive of related tax, except as otherwise noted)

    Number of

    common

    shares

     

    Share

    capital

     

    Contributed

    surplus

     

    (Loss) gain

    on currency

    translation

    of foreign

    operations

     

    Other

     

    Total

    AOCI

     

    Retained

    earnings

     

    Equity

    holders

    of

    Nutrien

     

    Non-

    controlling

    interest

     

    Total

    equity

    Balance – December 31, 2024

    491,025,446

     

    13,748

     

    68

     

    (537)

     

    22

     

    (515)

     

    11,106

     

    24,407

     

    35

     

    24,442

    Net earnings

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    11

     

    11

     

    8

     

    19

    Other comprehensive income (loss)

    ‐

     

    ‐

     

    ‐

     

    39

     

    (14)

     

    25

     

    ‐

     

    25

     

    ‐

     

    25

    Shares repurchased for cancellation (Note 7)

    (2,862,814)

     

    (80)

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (69)

     

    (149)

     

    ‐

     

    (149)

    Dividends declared1

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (266)

     

    (266)

     

    ‐

     

    (266)

    Non-controlling interest transactions

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (11)

     

    (11)

    Effect of share-based compensation including issuance of common shares

    59,751

     

    3

     

    1

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    4

     

    ‐

     

    4

    Transfer of net gain on sale of investment

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (27)

     

    (27)

     

    27

     

    ‐

     

    ‐

     

    ‐

    Transfer of net loss on cash flow hedges

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    6

     

    6

     

    ‐

     

    6

     

    ‐

     

    6

    Balance – March 31, 2025

    488,222,383

     

    13,671

     

    69

     

    (498)

     

    (13)

     

    (511)

     

    10,809

     

    24,038

     

    32

     

    24,070

    Balance – December 31, 2025

    481,962,233

     

    13,519

     

    57

     

    (329)

     

    ‐

     

    (329)

     

    12,076

     

    25,323

     

    42

     

    25,365

    Net earnings

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    131

     

    131

     

    8

     

    139

    Other comprehensive income (loss)

    ‐

     

    ‐

     

    ‐

     

    71

     

    (6)

     

    65

     

    ‐

     

    65

     

    1

     

    66

    Shares repurchased for cancellation (Note 7)

    (2,081,503)

     

    (58)

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (90)

     

    (148)

     

    ‐

     

    (148)

    Dividends declared1

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (264)

     

    (264)

     

    ‐

     

    (264)

    Non-controlling interest transactions

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (13)

     

    (13)

    Effect of share-based compensation including issuance of common shares

    876,975

     

    54

     

    (8)

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    46

     

    ‐

     

    46

    Transfer of net loss on cash flow hedges

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    1

     

    1

     

    ‐

     

    1

     

    ‐

     

    1

    Balance – March 31, 2026

    480,757,705

     

    13,515

     

    49

     

    (258)

     

    (5)

     

    (263)

     

    11,853

     

    25,154

     

    38

     

    25,192

    1 During the three months ended March 31, 2026, we declared dividends of $0.55 per share (2025 - $0.545 per share).

     

    (See Notes to the Condensed Consolidated Financial Statements)

     
     

    Condensed Consolidated Balance Sheets

     

     

     

     

    As at

     

     

    As at March 31

     

    December 31

    ($ millions)

    Note

    2026

     

    2025

     

    2025

    Assets

     

     

     

     

     

     

    Current assets

     

     

     

     

     

     

    Cash and cash equivalents

     

    777

     

    895

     

    701

    Receivables

    8

    6,284

     

    5,612

     

    5,675

    Inventories

     

    8,681

     

    7,992

     

    6,977

    Prepaid expenses and other current assets

     

    733

     

    863

     

    1,396

     

     

    16,475

     

    15,362

     

    14,749

    Non-current assets

     

     

     

     

     

     

    Property, plant and equipment

     

    22,659

     

    22,488

     

    22,747

    Goodwill

     

    12,176

     

    12,058

     

    12,136

    Intangible assets

     

    1,621

     

    1,791

     

    1,667

    Investments

     

    146

     

    495

     

    144

    Other assets

     

    846

     

    875

     

    858

    Total Assets

     

    53,923

     

    53,069

     

    52,301

    Liabilities

     

     

     

     

     

     

    Current liabilities

     

     

     

     

     

     

    Short-term debt

    6

    2,766

     

    2,437

     

    873

    Current portion of long-term debt

     

    1,036

     

    1,038

     

    513

    Current portion of lease liabilities

     

    362

     

    364

     

    346

    Trade, other payables and accrued liabilities

    8

    9,137

     

    8,752

     

    9,309

     

     

    13,301

     

    12,591

     

    11,041

    Non-current liabilities

     

     

     

     

     

     

    Long-term debt

     

    8,825

     

    9,870

     

    9,350

    Lease liabilities

     

    957

     

    998

     

    937

    Deferred income tax liabilities

     

    3,701

     

    3,591

     

    3,666

    Pension and other post-retirement benefit liabilities

     

    218

     

    225

     

    221

    Asset retirement obligations and accrued environmental costs

     

    1,478

     

    1,528

     

    1,468

    Other non-current liabilities

     

    251

     

    196

     

    253

    Total Liabilities

     

    28,731

     

    28,999

     

    26,936

    Shareholders' Equity

     

     

     

     

     

     

    Share capital

    7

    13,515

     

    13,671

     

    13,519

    Contributed surplus

     

    49

     

    69

     

    57

    Accumulated other comprehensive loss

     

    (263)

     

    (511)

     

    (329)

    Retained earnings

     

    11,853

     

    10,809

     

    12,076

    Equity holders of Nutrien

     

    25,154

     

    24,038

     

    25,323

    Non-controlling interest

     

    38

     

    32

     

    42

    Total Shareholders' Equity

     

    25,192

     

    24,070

     

    25,365

    Total Liabilities and Shareholders' Equity

     

    53,923

     

    53,069

     

    52,301

     

     

     

     

     

     

     

    (See Notes to the Condensed Consolidated Financial Statements)

     

    Notes to the Condensed Consolidated Financial Statements

    As at and for the Three Months Ended March 31, 2026

    Note 1 Basis of presentation

    Nutrien Ltd. (collectively with its subsidiaries, "Nutrien", "we", "us", "our" or "the Company") is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve the needs of farmers.

    These unaudited interim condensed consolidated financial statements ("interim financial statements") are based on International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board and have been prepared in accordance with IAS 34, "Interim Financial Reporting". The accounting policies and methods of computation used in preparing these interim financial statements are materially consistent with those used in the preparation of our 2025 annual audited consolidated financial statements with the exception of the amendments to IFRS 9 and IFRS 7, Amendments to the Classification and Measurement of Financial Instruments, which were adopted effective January 1, 2026 (refer to Note 9). These interim financial statements include the accounts of Nutrien and its subsidiaries; however, they do not include all disclosures normally provided in annual audited consolidated financial statements and should be read in conjunction with our 2025 annual audited consolidated financial statements. These interim financial statements are presented in millions of US dollars, unless otherwise indicated, which is the functional currency of Nutrien and the majority of its subsidiaries.

    Certain immaterial 2025 figures have been reclassified in Note 2 Segment information.

    In management's opinion, the interim financial statements include all adjustments necessary to fairly present such information in all material respects. Interim results are not necessarily indicative of the results expected for any other interim period or the fiscal year.

    These interim financial statements were authorized by the Audit Committee of the Board of Directors for issue on May 6, 2026.

    Note 2 Segment information

    We have four reportable operating segments: Retail, Potash, Nitrogen and Phosphate. Our downstream Retail segment distributes crop nutrients, crop protection products, seed and merchandise, and provides agronomic application services and solutions, including the services offered through Nutrien Financial. Retail also manufactures and distributes proprietary products and provides services directly to farmers through a network of retail locations in North America, Australia and South America. Our upstream Potash, Nitrogen and Phosphate segments are differentiated by the chemical nutrient contained in the products that each segment produces and are supported by midstream activities, which include the global sales, freight, transportation and distribution of our products, which are reported within these segments, respectively. Potash freight, transportation and distribution costs only apply to our North American potash sales volumes. Sales reported under our Corporate and Others segment relates to our non-core businesses. EBITDA presented in the succeeding tables is calculated as net earnings (loss) before finance costs, income taxes, and depreciation and amortization.

    Seasonality in our business results from increased demand for products during planting season. Crop input sales are generally higher in the spring and fall application seasons. Crop input inventories are normally accumulated leading up to each application season. Our cash collections generally occur after the application season is complete, while customer prepayments made to us are typically concentrated in December and January and inventory prepayments paid to our suppliers are typically concentrated in the period from November to January. Feed and industrial sales are more evenly distributed throughout the year.

    In the fourth quarter of 2025, the Chief Operating Decision Maker ("CODM") reassessed our product groupings and determined that the performance of our Purchase for Resale business should be evaluated as part of the Corporate and Others segment. It had previously been presented in our Nitrogen segment. The Purchase for Resale business focuses primarily on sales to international customers. Purchased product that remains in upstream is primarily purchases of inventory to satisfy sales contracts that we cannot fulfill with our manufactured products. The CODM concluded this change was appropriate based on the nature and strategic alignment of purchase for resale activities. Comparative amounts for the Corporate and Others and Nitrogen segments were reclassified. As a result of the reclassification, the Corporate and Others segment reflected the following increases and the Nitrogen segment reflected the corresponding decreases for the three months ended March 31, 2025.

     

     

    Three Months Ended

    ($ millions)

     

    March 31, 2025

    Sales

     

    70

    Gross Margin

     

    4

    EBITDA

     

    3

     

     

    Three Months Ended March 31, 2026

     

     

    Downstream

     

    Upstream and Midstream

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Corporate

     

     

     

     

    ($ millions)

    Retail

     

    Potash

     

    Nitrogen

     

    Phosphate

     

    and Others

     

    Eliminations

     

    Consolidated

    Sales

    – third party

    3,640

     

    966

     

    884

     

    478

     

    78

     

    ‐

     

    6,046

     

    – intersegment

    ‐

     

    75

     

    247

     

    69

     

    ‐

     

    (391)

     

    ‐

    Sales

    – total

    3,640

     

    1,041

     

    1,131

     

    547

     

    78

     

    (391)

     

    6,046

    Freight, transportation and distribution1

    ‐

     

    115

     

    117

     

    62

     

    ‐

     

    (50)

     

    244

    Net sales

    3,640

     

    926

     

    1,014

     

    485

     

    78

     

    (341)

     

    5,802

    Cost of goods sold

    2,840

     

    422

     

    647

     

    489

     

    64

     

    (306)

     

    4,156

    Gross margin

    800

     

    504

     

    367

     

    (4)

     

    14

     

    (35)

     

    1,646

    Selling expenses (recovery)

    798

     

    3

     

    6

     

    2

     

    (3)

     

    (7)

     

    799

    General and administrative expenses

    44

     

    3

     

    4

     

    2

     

    111

     

    ‐

     

    164

    Provincial mining taxes

    ‐

     

    90

     

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    90

    Share-based compensation expense

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    116

     

    ‐

     

    116

    Foreign exchange (gain) loss, net of related derivatives

    (2)

     

    ‐

     

    ‐

     

    ‐

     

    5

     

    ‐

     

    3

    Other expenses

    36

     

    26

     

    27

     

    7

     

    10

     

    8

     

    114

    Earnings (loss) before finance costs and income taxes

    (76)

     

    382

     

    330

     

    (15)

     

    (225)

     

    (36)

     

    360

    Depreciation and amortization

    184

     

    175

     

    152

     

    72

     

    23

     

    ‐

     

    606

    EBITDA

    108

     

    557

     

    482

     

    57

     

    (202)

     

    (36)

     

    966

    Restructuring costs (Note 3)

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    16

     

    ‐

     

    16

    Share-based compensation expense

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    116

     

    ‐

     

    116

    Impairment of assets recorded in other income and expenses (Note 3)

    ‐

     

    21

     

    ‐

     

    ‐

     

    9

     

    ‐

     

    30

    ARO/ERL related income for non-operating sites2 (Note 3)

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    (28)

     

    ‐

     

    (28)

    Foreign exchange loss, net of related derivatives

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    5

     

    ‐

     

    5

    Adjusted EBITDA

    108

     

    578

     

    482

     

    57

     

    (84)

     

    (36)

     

    1,105

    1 Potash freight, transportation and distribution costs only apply to our North American potash sales volumes.

    2 ARO/ERL refers to asset retirement obligations and accrued environmental costs.

     

     

    Three Months Ended March 31, 2025

     

     

    Downstream

     

    Upstream and Midstream

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Corporate

     

     

     

     

    ($ millions)

    Retail

     

    Potash

    Nitrogen1

     

    Phosphate

     

    and Others1

     

    Eliminations

     

    Consolidated

    Sales

    – third party

    3,090

     

    766

    822

     

    338

     

    84

     

    ‐

     

    5,100

     

    – intersegment

    ‐

     

    95

    182

     

    67

     

    ‐

     

    (344)

     

    ‐

    Sales

    – total

    3,090

     

    861

    1,004

     

    405

     

    84

     

    (344)

     

    5,100

    Freight, transportation and distribution2

    ‐

     

    117

    119

     

    45

     

    1

     

    (56)

     

    226

    Net sales

    3,090

     

    744

    885

     

    360

     

    83

     

    (288)

     

    4,874

    Cost of goods sold

    2,404

     

    380

    598

     

    361

     

    69

     

    (258)

     

    3,554

    Gross margin

    686

     

    364

    287

     

    (1)

     

    14

     

    (30)

     

    1,320

    Selling expenses (recovery)

    755

     

    3

    7

     

    2

     

    (3)

     

    (7)

     

    757

    General and administrative expenses

    44

     

    2

    5

     

    2

     

    99

     

    ‐

     

    152

    Provincial mining taxes

    ‐

     

    68

    ‐

     

    ‐

     

    ‐

     

    ‐

     

    68

    Share-based compensation expense

    ‐

     

    ‐

    ‐

     

    ‐

     

    42

     

    ‐

     

    42

    Foreign exchange loss, net of related derivatives

    ‐

     

    ‐

    ‐

     

    ‐

     

    7

     

    ‐

     

    7

    Other expenses

    25

     

    2

    12

     

    6

     

    18

     

    5

     

    68

    Earnings (loss) before finance costs and income taxes

    (138)

     

    289

    263

     

    (11)

     

    (149)

     

    (28)

     

    226

    Depreciation and amortization

    184

     

    157

    142

     

    72

     

    16

     

    ‐

     

    571

    EBITDA

    46

     

    446

    405

     

    61

     

    (133)

     

    (28)

     

    797

    Restructuring costs (Note 3)

    ‐

     

    ‐

    ‐

     

    ‐

     

    1

     

    ‐

     

    1

    Share-based compensation expense

    ‐

     

    ‐

    ‐

     

    ‐

     

    42

     

    ‐

     

    42

    ARO/ERL related expenses for non-operating sites (Note 3)

    ‐

     

    ‐

    ‐

     

    ‐

     

    5

     

    ‐

     

    5

    Foreign exchange loss, net of related derivatives

    ‐

     

    ‐

    ‐

     

    ‐

     

    7

     

    ‐

     

    7

    Adjusted EBITDA

    46

     

    446

    405

     

    61

     

    (78)

     

    (28)

     

    852

    1 Comparative figures have been reclassified for our Purchase for Resale business from Nitrogen to the Corporate and Others segment.

    2 Potash freight, transportation and distribution costs only apply to our North American potash sales volumes.

     

    Three Months Ended

     

    March 31

    ($ millions)

    2026

     

    2025

    Retail sales by product line

     

     

     

    Crop nutrients

    1,483

     

    1,194

    Crop protection products

    1,137

     

    972

    Seed

    562

     

    532

    Services and other

    175

     

    146

    Merchandise

    223

     

    189

    Nutrien Financial

    80

     

    70

    Nutrien Financial elimination1

    (20)

     

    (13)

     

    3,640

     

    3,090

    Potash sales by geography

     

     

     

    Manufactured product

     

     

     

    North America

    484

     

    434

    Offshore2

    557

     

    426

    Other potash and purchased products

    ‐

     

    1

     

    1,041

     

    861

    Nitrogen sales by product line

     

     

     

    Manufactured product

     

     

     

    Ammonia

    167

     

    240

    Urea and ESN®

    416

     

    382

    Solutions, nitrates and sulfates

    416

     

    321

    Other nitrogen and purchased products3

    132

     

    61

     

    1,131

     

    1,004

    Phosphate sales by product line

     

     

     

    Manufactured product

     

     

     

    Fertilizer

    359

     

    249

    Industrial and feed

    183

     

    151

    Other phosphate and purchased products

    5

     

    5

     

    547

     

    405

    1 Represents elimination of the interest and service fees charged by Nutrien Financial to Retail branches.

    2 Relates to Canpotex Limited ("Canpotex") (see Note 8) and includes provisional pricing adjustments for the three months ended March 31, 2026 of $(3) million (2025 – $31 million).

    3 Comparative figures have been reclassified for our Purchase for Resale business from Nitrogen to the Corporate and Others segment.

    Note 3 Other expenses (income)

     

    Three Months Ended

     

    March 31

    ($ millions)

    2026

     

    2025

    Restructuring costs

    16

     

    1

    Earnings of equity-accounted investees

    (2)

     

    (5)

    Bad debt expense

    15

     

    19

    Project feasibility costs

    18

     

    15

    Customer prepayment costs

    19

     

    18

    Legal expenses

    5

     

    5

    ARO/ERL related (income) expenses for non-operating sites

    (28)

     

    5

    Impairment of assets

    30

     

    ‐

    Other expenses

    41

     

    10

     

    114

     

    68

    Note 4 Income taxes

     

    Three Months Ended

     

    March 31

    ($ millions, except as otherwise noted)

    2026

     

    2025

    Actual effective tax rate on earnings (%)

    29

     

    49

    Actual effective tax rate including discrete items (%)

    24

     

    60

    Discrete tax adjustments that impacted the tax rate1

    (8)

     

    5

    1 Discrete tax adjustments arise from specific, significant or unusual events that are recognized in the period in which the event occurs, rather than being allocated across the year through the annual effective tax rate.

    Note 5 Financial instruments

    During the three months ended March 31, 2026, we entered into interest rate derivative contracts to manage exposure to changes in variable interest rates on certain long-term debt instruments.

    The following table presents the Company's interest rate derivatives outstanding as at March 31, 2026:

     

    As at March 31, 2026

     

     

     

    Maturities

     

    Average fixed

     

    Fair value of

    ($ millions, except as otherwise noted)

    Notional1

     

    (year)

     

    interest rate (%)

     

    assets2

    Interest rate derivatives - 5-year

    250

     

    2026

     

    3.6473

     

    3

    Interest rate derivatives - 10-year

    350

     

    2026

     

    4.0774

     

    8

    1 Notional amounts represent the gross contractual amount outstanding.

    2 Fair value of interest rate derivatives are based on a discounted cash flow model using observable market inputs which are classified as Level 2.

    Our financial instruments carrying amounts are a reasonable approximation of their fair values, except for our long-term debt, including current portion, that has a carrying value of $9,861 million and fair value of $9,372 million as at March 31, 2026. There were no transfers between levels for financial instruments measured at fair value on a recurring basis.

    Note 6 Debt

    On March 3, 2026, we entered into a $69 million uncommitted revolving demand facility. As at March 31, 2026, there were no borrowings outstanding under this facility.

    During the three months ended March 31, 2026, we extended the maturity of our accounts receivable purchase facility from March 6, 2026 to March 31, 2028.

    Note 7 Share capital

    Share repurchase programs

    The following table summarizes our share repurchase activities during the periods indicated below:

     

    Three Months Ended

     

    March 31

    ($ millions, except as otherwise noted)

    2026

     

    2025

    Number of common shares repurchased for cancellation

    2,081,503

     

    2,862,814

    Average price per share (US dollars)

    70.97

     

    51.08

    Total cost, inclusive of tax

    148

     

    149

    Subsequent to March 31, 2026, as of May 5, 2026, an additional 865,577 common shares were repurchased for cancellation at a cost of $66 million and an average price per share of $73.71.

    Dividends declared

    We declared a dividend per share of $0.55 (2025 – $0.545) during the three months ended March 31, 2026, payable on April 16, 2026 to shareholders of record on March 31, 2026.

    Note 8 Related party transactions

    We sell potash outside Canada and the US exclusively through Canpotex. Our total revenue is recognized, at the time product is loaded for shipping, at the amount received from Canpotex representing proceeds from their sale of potash, less net costs of Canpotex. The receivable outstanding from Canpotex arose from sale transactions described above. It is unsecured and bears no interest. Any credit losses held against this receivable are expected to be negligible. Canpotex sells potash to buyers, including Nutrien, in export markets pursuant to term and spot contracts at agreed-upon prices. Purchases from Canpotex for the three months ended March 31, 2026 were $64 million (2025 – $57 million).

     

     

    As at

     

    As at

    ($ millions)

     

    March 31, 2026

     

    December 31, 2025

    Receivables from Canpotex

     

    293

     

    279

    Payables to Canpotex

     

    74

     

    63

    Note 9 Accounting policies, estimates and judgments

    Amendments to IFRS 9 and IFRS 7, Amendments to the Classification and Measurement of Financial Instruments

    Amendments to IFRS 9 and IFRS 7, Amendments to the Classification and Measurement of Financial Instruments, were adopted effective January 1, 2026, the required adoption date. The amendments clarified the timing of recognition and derecognition of financial assets and financial liabilities. The adoption resulted in a change in the accounting policy relating to the timing of the derecognition of certain financial assets and financial liabilities, such that derecognition now occurs upon settlement.

    The amendments were applied retrospectively without restatement of prior periods in accordance with the transitional provisions other than, on initial adoption, there was an adjustment of $(13) million to opening cash and cash equivalents as at January 1, 2026, which has been reflected in the condensed consolidated statement of cash flows for the three months ended March 31, 2026.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260428899674/en/

    For Further Information:

    Investor Contact:

    Jeff Holzman

    Senior Vice President, Investor Relations and FP&A

    (306) 933-8545 – investors@nutrien.com

    Media Contact:

    Simon Scott

    Vice President, Global Communications

    (403) 225-7213 – media@nutrien.com

    Get the next $NTR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NTR

    DatePrice TargetRatingAnalyst
    5/5/2026$90.00Mkt Perform → Outperform
    Raymond James
    4/30/2026$82.00Neutral → Buy
    BofA Securities
    4/27/2026$85.00Equal Weight → Overweight
    Barclays
    3/26/2026$67.00Neutral → Sell
    UBS
    3/13/2026$100.00Equal Weight → Overweight
    Wells Fargo
    3/12/2026$96.00Hold → Buy
    Jefferies
    2/23/2026Outperform → Neutral
    BNP Paribas Exane
    1/14/2026$77.00Equal-Weight → Overweight
    Morgan Stanley
    More analyst ratings

    $NTR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nutrien Prices Offering of an Aggregate of US$1.0 Billion of 5-Year and 10-Year Senior Notes

    Nutrien Ltd. (TSX and NYSE:NTR) today announced the pricing of US$500 million aggregate principal amount of 4.850 percent senior notes due May 29, 2031 and US$500 million aggregate principal amount of 5.350 percent senior notes due May 29, 2036 (together, the "senior notes"). The offering is expected to close on or about May 29, 2026, subject to customary closing conditions. Nutrien intends to use the net proceeds from this offering to repay its US$500 million aggregate principal amount of 4.000% senior notes upon their maturity on December 15, 2026, to reduce outstanding indebtedness under its short-term credit facilities, to finance working capital and for general corporate purposes. Th

    5/26/26 7:00:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Kayne Anderson Energy Infrastructure Fund Announces Appointment of Michael J. Hennigan as New Independent Director

    HOUSTON, May 12, 2026 (GLOBE NEWSWIRE) -- Kayne Anderson Energy Infrastructure Fund, Inc. (the "Company" or "KYN") announced today the appointment of Michael J. Hennigan as an independent director of the Company, effective immediately. Following the retirements of William R. Cordes and Barry R. Pearl earlier this year, the appointment of Mr. Hennigan brings the Company's Board to six members, five of whom are independent. Michael J. Hennigan is a highly accomplished energy executive, with several decades of leadership experience in the refining and midstream sectors. Mr. Hennigan most recently served as Executive Chairman of Marathon Petroleum Corporation (NYSE:MPC) and MPLX LP (NYSE:MPLX

    5/12/26 4:20:00 PM ET
    $CI
    $KYN
    $MPC
    Medical Specialities
    Health Care
    Finance/Investors Services
    Finance

    Nutrien Announces Mark Thompson as a Speaker at the BMO Farm to Market Conference

    Nutrien Ltd. (TSX and NYSE:NTR) announced today that Mr. Mark Thompson, Nutrien's Executive Vice President and Chief Financial Officer, will be speaking at the BMO Farm to Market Conference on Wednesday, May 13 at 8:45am EDT. The fireside chat will be video cast and available on the Company's website at https://www.nutrien.com/investors/events. About Nutrien Nutrien is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve the needs of growers. We focus on creating long-term value by prioritizing investments that strengthen the advantages of our business across

    5/8/26 11:00:00 AM ET
    $NTR
    Agricultural Chemicals
    Industrials

    $NTR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Nutrien upgraded by Raymond James with a new price target

    Raymond James upgraded Nutrien from Mkt Perform to Outperform and set a new price target of $90.00

    5/5/26 12:26:31 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien upgraded by BofA Securities with a new price target

    BofA Securities upgraded Nutrien from Neutral to Buy and set a new price target of $82.00

    4/30/26 7:15:05 AM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien upgraded by Barclays with a new price target

    Barclays upgraded Nutrien from Equal Weight to Overweight and set a new price target of $85.00

    4/27/26 8:24:14 AM ET
    $NTR
    Agricultural Chemicals
    Industrials

    $NTR
    SEC Filings

    View All

    SEC Form 6-K filed by Nutrien Ltd.

    6-K - Nutrien Ltd. (0001725964) (Filer)

    5/29/26 4:43:03 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    SEC Form 6-K filed by Nutrien Ltd.

    6-K - Nutrien Ltd. (0001725964) (Filer)

    5/27/26 5:11:44 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    SEC Form SUPPL filed by Nutrien Ltd.

    SUPPL - Nutrien Ltd. (0001725964) (Filer)

    5/27/26 5:09:05 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    $NTR
    Leadership Updates

    Live Leadership Updates

    View All

    Kayne Anderson Energy Infrastructure Fund Announces Appointment of Michael J. Hennigan as New Independent Director

    HOUSTON, May 12, 2026 (GLOBE NEWSWIRE) -- Kayne Anderson Energy Infrastructure Fund, Inc. (the "Company" or "KYN") announced today the appointment of Michael J. Hennigan as an independent director of the Company, effective immediately. Following the retirements of William R. Cordes and Barry R. Pearl earlier this year, the appointment of Mr. Hennigan brings the Company's Board to six members, five of whom are independent. Michael J. Hennigan is a highly accomplished energy executive, with several decades of leadership experience in the refining and midstream sectors. Mr. Hennigan most recently served as Executive Chairman of Marathon Petroleum Corporation (NYSE:MPC) and MPLX LP (NYSE:MPLX

    5/12/26 4:20:00 PM ET
    $CI
    $KYN
    $MPC
    Medical Specialities
    Health Care
    Finance/Investors Services
    Finance

    Nutrien Announces Results of 2026 Annual Meeting

    Nutrien Ltd. (TSX and NYSE:NTR) announced today the results of its annual meeting of shareholders held on May 6, 2026 (the "Meeting"). A total of 366,120,629 common shares, representing 76.09% of common shares outstanding, were represented at the Meeting. Results of the matters voted on at the Meeting are set out below. Election of Directors Nutrien's 12 director nominees were elected: Votes For (percent) Votes Against (percent) Christopher M. Burley 97.75% 2.25% Maura J. Clark 99.14% 0.86% Russell K. Girling 98.11% 1.89% Michael J. Hennigan 97.77% 2.23% Miranda C. Hubbs 97.26%

    5/6/26 7:08:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Announces Results of 2025 Annual Meeting

    Nutrien Ltd. (TSX and NYSE:NTR) announced today the results of its annual meeting of shareholders held on May 7, 2025 (the "Meeting"). A total of 488,556,988 common shares, representing 74.48% of common shares outstanding, were represented at the Meeting. Results of the matters voted on at the Meeting are set out below. Election of Directors Nutrien's 12 director nominees were elected: Votes For (percent) Votes Against (percent) Christopher M. Burley 98.02% 1.98% Maura J. Clark 98.88% 1.12% Russell K. Girling 96.64% 3.36% Michael J. Hennigan 96.21% 3.79% Miranda C. Hubbs 98.20% 1.80% Raj S. Kushwaha 98.88% 1.12%

    5/7/25 8:31:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    $NTR
    Financials

    Live finance-specific insights

    View All

    Nutrien Declares Quarterly Dividend of US$0.55 per Share

    Nutrien Ltd. (TSX and NYSE:NTR) announced today that its Board of Directors has declared a quarterly dividend of US$0.55 per share payable on July 17, 2026, to shareholders of record on June 30, 2026. Registered shareholders who are residents of Canada as reflected in Nutrien's shareholders register, as well as beneficial holders (i.e., shareholders who hold their common shares through a broker or other intermediary) whose intermediary is a participant in CDS Clearing and Depositary Services Inc. or its nominee, CDS & Co., will receive their dividend in Canadian dollars, calculated based on the Bank of Canada daily average exchange rate on June 30, 2026. Registered shareholders resident o

    5/6/26 5:07:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Reports First Quarter 2026 Results

    Strong customer demand and solid operational performance in the first quarter Strategic priorities and capital allocation approach remain unchanged Full-year guidance ranges reaffirmed All amounts are in US dollars, except as otherwise noted Nutrien Ltd. (TSX and NYSE:NTR) announced today its first quarter 2026 results, with net earnings of $139 million ($0.27 diluted net earnings per share). First quarter 2026 adjusted EBITDA1 was $1.11 billion and adjusted net earnings per share1 was $0.51. "Nutrien delivered record potash sales volumes and stronger Nitrogen and Retail performance in the first quarter. We increased production from our low-cost North American assets and positione

    5/6/26 5:00:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Announces Release Dates for First Quarter 2026 Results and Conference Call

    Nutrien Ltd. (TSX and NYSE:NTR) announced today plans to release first quarter 2026 results after market close on Wednesday, May 6. Nutrien will host a conference call to discuss its results and outlook at 10:00 a.m. EDT on Thursday, May 7. Investors can access the call by dialing 1-800-990-2777 or 1-416-855-9085 and using conference ID: 89180. A webcast of the call can be accessed by visiting Nutrien's Investor Events and Presentation page. A recording of the call will be available after its completion and can be accessed at www.nutrien.com/news/events. The webcast link will be live for 12 months following the call. About Nutrien Nutrien is a leading global provider of crop inputs

    4/9/26 5:00:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials